Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Search Results to Victor Blanchette

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Blanchette, Victor

Item TypeName
Concept von Willebrand Factor
Concept Factor IX
Concept Factor VIII
Concept Factor VIIa
Concept Factor VII
Concept Blood Coagulation Factor Inhibitors
Concept Granulocyte-Macrophage Colony-Stimulating Factor
Academic Article The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults.
Academic Article Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.
Academic Article Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors.
Academic Article Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.
Academic Article Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII.
Academic Article Outcome measures in haemophilia: more than just factor levels.
Academic Article The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants.
Academic Article Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UK.
Academic Article The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
Academic Article Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions.
Academic Article Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Academic Article Clinical and cost implications of target joints in Canadian boys with severe hemophilia A.
Academic Article A survey of factor prophylaxis in the Canadian haemophilia A population.
Academic Article Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
Academic Article Cost of severe haemophilia in Toronto.
Academic Article Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT.
Academic Article Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.
Academic Article Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.
Academic Article Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.
Academic Article Managing the pediatric patient and the adolescent/adult transition.
Academic Article Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.
Academic Article Platelet activation and von Willebrand factor binding to platelets in newborn infants with central venous lines.
Academic Article Different clinical phenotype in triplets with haemophilia A.
Academic Article Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding.
Academic Article Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
Academic Article Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients.
Academic Article Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
Academic Article The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Academic Article Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A.
Academic Article In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A.
Academic Article Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.
Academic Article Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring.
Academic Article Meeting unmet needs in inhibitor patients.
Academic Article Prophylaxis in the haemophilia population.
Academic Article Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.
Academic Article Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
Academic Article Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study.
Academic Article When should prophylaxis therapy in inhibitor patients be considered?
Academic Article Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease.
Academic Article Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.
Academic Article Clinical trial design in haemophilia.
Academic Article An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group.
Academic Article Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group.
Academic Article PRO-PACT: retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors.
Academic Article A Canadian survey of self-infusion practices in persons with haemophilia A.
Academic Article The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
Academic Article Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Academic Article Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 µg kg?¹) rFVIIa doses across clinical trials and registries.
Academic Article Hepatitis C infection in children with hemophilia A and B.
Academic Article Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.
Academic Article Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease.
Academic Article Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.
Academic Article A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatment.
Academic Article Variation of the non-factor VIII sequences detected by a probe from intron 22 of the factor VIII gene.
Academic Article Assessments of outcome in haemophilia - what is the added value of QoL tools?
Academic Article Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Academic Article Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.
Academic Article Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.
Academic Article Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A.
Academic Article Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates.
Academic Article Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX.
Academic Article Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
Academic Article Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.
Academic Article Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH.
Academic Article A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred.
Academic Article Carrier detection of haemophilia A using DNA markers in families with an isolated affected male.
Academic Article Recombination between the factor VIII gene and the DXS52 locus gives the most probable genetic order as centromere-fra(X)-DXS15-DXS52-F8C-telomere.
Academic Article Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia.
Academic Article Hepatitis C infection in patients with hemophilia: results of a national survey. Canadian Hemophilia Clinic Directors Group.
Academic Article Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII.
Academic Article Central venous access catheters in children with haemophilia.
Academic Article Central venous access devices in children with hemophilia: an update.
Academic Article Recombinant factor VIII in hemophilia A: the Canadian experience.
Academic Article Platelet activation induced by porcine factor VIII (Hyate:C).
Academic Article The impact of inhibitors on the cost of clotting factor replacement therapy in Haemophilia A in Canada.
Academic Article von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Academic Article Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C).
Academic Article Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique.
Academic Article DDAVP challenge tests in boys with mild/moderate haemophilia A.
Academic Article Unresolved issues in prophylaxis.
Academic Article A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres.
Academic Article Defining extended half-life rFVIII-A critical review of the evidence.
Academic Article Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
Academic Article Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII.
Academic Article Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study.
Academic Article Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study.
Academic Article Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?
Academic Article Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
Academic Article Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool.
Academic Article Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis.

Search criteria
  • Factor X